{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T12:13:56Z","timestamp":1794053636097,"version":"4.8.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Endosc"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Introduction<\/jats:title>\n            <jats:p>The American Society for Gastrointestinal Endoscopy (ASGE) guidelines for common bile duct (CBD) stone management were created to risk stratify patients into low, intermediate, and high-risk groups to optimize interventions. Low-risk patients typically proceed to cholecystectomy with or without Intra-operative cholangiogram (IOC) whereas high-risk patients typically proceed to common duct clearance. The optimum management of intermediate-risk patients still widely varies. This study aims to characterize the use of MRCP, IOC, and endoscopic ultrasound (EUS) in patients with intermediate risk of CBD stones.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods and procedures<\/jats:title>\n            <jats:p>This is a retrospective analysis of data from the Eastern Association for the Surgery of Trauma (EAST) Retained Common Bile Duct stone database comprised of deidentified data and outcomes of patients prospectively admitted with suspected CBD stones and\/or acute biliary pancreatitis from 12 US medical centers between 2016 and 2019. Analysis of the testing characteristics sensitivity (SN), specificity (SP), and predictive values (positive (PPV) and negative (NPV)) were calculated for MRCP, EUS, and IOC based on definitive identification of CBD stones.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>736 patients met inclusion criteria. 521 met the ASGE intermediate risk of choledocholithiasis criteria. 208\/521 (39.9%) underwent pre-op MRCP, 44\/521 (8.4%) underwent pre-op EUS, and 238\/521 (45.7%) underwent IOC.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>There is little role for MRCP for ASGE intermediate-risk patients as this modality has both lower sensitivity and specificity than EUS and IOC. When available, either EUS or IOC is the preferred option for diagnostic clarification to identify the choledocholithiasis in this group.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s00464-025-12054-z","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T18:14:48Z","timestamp":1755108888000},"page":"6525-6529","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Suspected common bile duct stones: Which test is best?"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1008-0123","authenticated-orcid":false,"given":"Andrew","family":"Varone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April","family":"Mendoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rondi","family":"Gelbard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett","family":"Tracy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Poulose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,13]]},"reference":[{"issue":"1","key":"12054_CR1","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/s13643-022-02135-8","volume":"11","author":"R Shenoy","year":"2022","unstructured":"Shenoy R, Kirkland P, Hadaya JE et al (2022) Management of symptomatic cholelithiasis: a systematic review. Syst Rev 11(1):267. https:\/\/doi.org\/10.1186\/s13643-022-02135-8","journal-title":"Syst Rev"},{"issue":"2","key":"12054_CR2","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1097\/TA.0000000000003466","volume":"92","author":"BM Tracy","year":"2022","unstructured":"Tracy BM, Poulose BK, Paterson CW et al (2022) National adherence to the ASGE-SAGES guidelines for managing suspected choledocholithiasis: an EAST multicenter study. J Trauma Acute Care Surg 92(2):305\u2013312. https:\/\/doi.org\/10.1097\/TA.0000000000003466","journal-title":"J Trauma Acute Care Surg"},{"issue":"6","key":"12054_CR3","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/j.gie.2018.10.001","volume":"89","author":"JL Buxbaum","year":"2019","unstructured":"Buxbaum JL, Abbas Fehmi SM, Sultan S et al (2019) ASGE guideline on the role of endoscopy in the evaluation and management of choledocholithiasis. Gastrointest Endosc 89(6):1075-1105.e15. https:\/\/doi.org\/10.1016\/j.gie.2018.10.001","journal-title":"Gastrointest Endosc"},{"issue":"28","key":"12054_CR4","doi-asserted-by":"publisher","first-page":"4536","DOI":"10.3748\/wjg.v27.i28.4536","volume":"27","author":"P Cianci","year":"2021","unstructured":"Cianci P, Restini E (2021) Management of cholelithiasis with choledocholithiasis: endoscopic and surgical approaches. World J Gastroenterol 27(28):4536\u20134554. https:\/\/doi.org\/10.3748\/wjg.v27.i28.4536","journal-title":"World J Gastroenterol"},{"issue":"4","key":"12054_CR5","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.gie.2010.06.033","volume":"72","author":"JL Frossard","year":"2010","unstructured":"Frossard JL, Morel PM (2010) Detection and management of bile duct stones. Gastrointest Endosc 72(4):808\u2013816. https:\/\/doi.org\/10.1016\/j.gie.2010.06.033","journal-title":"Gastrointest Endosc"},{"key":"12054_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003327.pub4","author":"BV Dasari","year":"2013","unstructured":"Dasari BV, Tan CJ, Gurusamy KS et al (2013) Surgical versus endoscopic treatment of bile duct stones. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD003327.pub4","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"12054_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gie.2009.09.041","volume":"71","author":"JT Maple","year":"2010","unstructured":"Maple JT, Ben-Menachem T, Anderson MA et al (2010) The role of endoscopy in the evaluation of suspected choledocholithiasis. Gastrointest Endosc 71(1):1\u20139. https:\/\/doi.org\/10.1016\/j.gie.2009.09.041","journal-title":"Gastrointest Endosc"},{"issue":"1","key":"12054_CR8","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.gie.2016.06.051","volume":"85","author":"V Chandrasekhara","year":"2017","unstructured":"Chandrasekhara V, Khashab MA, Muthusamy VR et al (2017) Adverse events associated with ERCP. Gastrointest Endosc 85(1):32\u201347. https:\/\/doi.org\/10.1016\/j.gie.2016.06.051","journal-title":"Gastrointest Endosc"},{"key":"12054_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011549","author":"V Giljaca","year":"2015","unstructured":"Giljaca V, Gurusamy KS, Takwoingi Y et al (2015) Endoscopic ultrasound versus magnetic resonance cholangiopancreatography for common bile duct stones. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD011549","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"12054_CR10","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.gie.2017.06.009","volume":"86","author":"Y Meeralam","year":"2017","unstructured":"Meeralam Y, Al-Shammari K, Yaghoobi M (2017) Diagnostic accuracy of EUS compared with MRCP in detecting choledocholithiasis: a meta-analysis of diagnostic test accuracy in head-to-head studies. Gastrointest Endosc 86(6):986\u2013993. https:\/\/doi.org\/10.1016\/j.gie.2017.06.009","journal-title":"Gastrointest Endosc"},{"issue":"7","key":"12054_CR11","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1177\/000313481508100724","volume":"81","author":"C Lin","year":"2015","unstructured":"Lin C, Collins JN, Britt RC, Britt LD (2015) Initial cholecystectomy with cholangiography decreases length of stay compared to preoperative MRCP or ERCP in the management of choledocholithiasis. Am Surg 81(7):726\u2013731","journal-title":"Am Surg"},{"issue":"7","key":"12054_CR12","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1177\/000313481508100723","volume":"81","author":"WH Ward","year":"2015","unstructured":"Ward WH, Fluke LM, Hoagland BD, Zarow GJ, Held JM, Ricca RL (2015) The role of magnetic resonance cholangiopancreatography in the diagnosis of choledocholithiasis: do benefits outweigh the costs? Am Surg 81(7):720\u2013725","journal-title":"Am Surg"},{"issue":"2","key":"12054_CR13","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.amjsurg.2016.10.025","volume":"214","author":"WR Badger","year":"2017","unstructured":"Badger WR, Borgert AJ, Kallies KJ, Kothari SN (2017) Utility of MRCP in clinical decision making of suspected choledocholithiasis: an institutional analysis and literature review. Am J Surg 214(2):251\u2013255. https:\/\/doi.org\/10.1016\/j.amjsurg.2016.10.025","journal-title":"Am J Surg"},{"issue":"2","key":"12054_CR14","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.gie.2021.08.024","volume":"95","author":"FS Ali","year":"2022","unstructured":"Ali FS, DaVee T, Bernstam EV et al (2022) Cost-effectiveness analysis of optimal diagnostic strategy for patients with symptomatic cholelithiasis with intermediate probability for choledocholithiasis. Gastrointest Endosc 95(2):327\u2013338. https:\/\/doi.org\/10.1016\/j.gie.2021.08.024","journal-title":"Gastrointest Endosc"},{"issue":"5","key":"12054_CR15","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s11605-013-2179-4","volume":"17","author":"I Epelboym","year":"2013","unstructured":"Epelboym I, Winner M, Allendorf JD (2013) MRCP is not a cost-effective strategy in the management of silent common bile duct stones. J Gastrointest Surg 17(5):863\u2013871. https:\/\/doi.org\/10.1007\/s11605-013-2179-4","journal-title":"J Gastrointest Surg"},{"issue":"1","key":"12054_CR16","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13017-023-00521-8","volume":"18","author":"S Campbell","year":"2023","unstructured":"Campbell S, Lee SH, Liu Y, Wren SM (2023) A retrospective study of laparoscopic, robotic-assisted, and open emergent\/urgent cholecystectomy based on the PINC AI healthcare database 2017\u20132020. World J Emerg Surg 18(1):55. https:\/\/doi.org\/10.1186\/s13017-023-00521-8","journal-title":"World J Emerg Surg"}],"container-title":["Surgical Endoscopy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-025-12054-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00464-025-12054-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-025-12054-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T20:03:43Z","timestamp":1759781023000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00464-025-12054-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,13]]},"references-count":16,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["12054"],"URL":"https:\/\/doi.org\/10.1007\/s00464-025-12054-z","relation":{},"ISSN":["0930-2794","1432-2218"],"issn-type":[{"value":"0930-2794","type":"print"},{"value":"1432-2218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,13]]},"assertion":[{"value":"10 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Drs. Andrew Varone, Brett Tracy,  and April Mendoza have nothing to disclose. Dr. Benjamin Poulose receives research support from BD interventional and Advanced Medical Devices. He is a consultant for Abbvie-Allergan. He receives salary support from the Abdominal Core Health Quality Collaborative and he has equity in EndoEvolve LLC. Dr. Rondi Gelbard serves in an unpaid role as the Chair of the Scientific Studies Committee for the Surgical Infection Society.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}